This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1046/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51550717
rdf:type
wikibase:Item
schema:description
научная статья articolo scientifico 1999 nî lūn-bûn scienca artikolo tudományos cikk scientific article published in May 1999 научни чланак 1999年學術文章 artigo científico article scientific artikel ilmiah scientific article published in May 1999 teaduslik artikkel artículo científico publicado en 1999 artikull shkencor מאמר מדעי vitenskapelig artikkel επιστημονικό άρθρο 1999年學術文章 სამეცნიერო სტატია bài báo khoa học 1999年学术文章 vetenskaplig artikel 1999年學術文章 vedecký článok artykuł naukowy مقالة علمية نشرت في مايو 1999 মে ১৯৯৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 1999年の論文 articol științific artigo científico 1999년 논문 wissenschaftlicher Artikel naučni članak 1999年学术文章 scientific article published in May 1999 vědecký článek artikulong pang-agham 1999年學術文章 videnskabelig artikel научна статия мақолаи илмӣ 1999年学术文章 наукова стаття, опублікована в травні 1999 บทความทางวิทยาศาสตร์ artículu científicu 1999年學術文章 научни чланак 1999年学术文章 bilimsel makale artigo científico 1999年学术文章 wetenschappelijk artikel 1999年学术文章 article scientifique vitskapeleg artikkel tieteellinen artikkeli article científic
p:P577
wds:Q51550717-C1E9D90E-DFA6-4D94-9CCA-EC355CDF6673
wdt:P577
1999-05-01T00:00:00Z
p:P2860
wds:Q51550717-37E14C47-7BD1-4EAA-B52D-F311654867AC wds:Q51550717-679DD8B8-380A-40A0-934B-E87F9E6C46CC wds:Q51550717-79DA9A5C-97C4-4A71-8027-AF26254BBDA9 wds:Q51550717-078C02E4-BBAA-4A16-B859-E32CCA26981C wds:Q51550717-16868174-BEF3-4834-A7C0-AB0DAB835F01 wds:Q51550717-1E46CBF2-9319-4D6E-BD76-AFFE84D2B8B6 wds:Q51550717-BC154FB4-0F2A-4C2C-8AB9-8DFA03D28C0C wds:Q51550717-E7F6B796-C396-4D24-9C34-9443CFFDBD5F wds:Q51550717-F08FDC7D-0106-4954-89F1-B6BC6734460C wds:Q51550717-A0B08CA7-0FCC-4BB9-A1BA-F384476BBB39 wds:Q51550717-A30828F9-E08B-4415-9B85-FE5A46ACFBB7 wds:Q51550717-AAE74CE7-DE66-4DC2-AC62-AE1EA3BAE6A5 wds:Q51550717-AD58E223-6BAE-4585-A741-BC306803106B wds:Q51550717-F839B33B-AB16-4523-BA8C-EACC4F9AA00F wds:Q51550717-F8C90C9A-8C7B-4DB3-8CF6-E3D38E655D20
wdt:P2860
wd:Q34326121 wd:Q50974010 wd:Q34323376 wd:Q51581141 wd:Q27860882 wd:Q46592049 wd:Q29547282 wd:Q41217443 wd:Q44459441 wd:Q41308183 wd:Q51571877 wd:Q38287981 wd:Q43810405 wd:Q37376673 wd:Q43832606
p:P2093
wds:Q51550717-FF5410F8-EE70-4BFC-A933-A23286DF44D4 wds:Q51550717-DB310C63-10A5-4CCB-83EF-84BE648D1D37 wds:Q51550717-BAE24A83-BB0F-4924-A62D-2789E85319D5
wdt:P2093
Rappaport EB Anderson RJ Patel J
rdfs:label
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
skos:prefLabel
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
schema:name
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
p:P1476
wds:Q51550717-AE155E15-D83B-4808-A11E-C92689CFACB1
wdt:P1476
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
p:P304
wds:Q51550717-2482CB4C-60E8-4AE8-9FAB-213AFA484CDC
wdt:P304
165-172
p:P31
wds:Q51550717-843BA7E8-D946-4C2C-A2AA-299F147DE95F
wdt:P31
wd:Q13442814
p:P921
wds:Q51550717-19C2B8DC-CF98-45BE-9C6A-5CB7D59DC5B0 wds:Q51550717-A243D879-42B2-4B3F-848B-D6074EA80DBD wds:Q51550717-88F19D32-878F-49DD-BE31-B3038ADCB84F wds:Q51550717-8C588A0B-14FA-4E6B-BDDD-4B0A72C9F5B1
wdt:P921
wd:Q3025883 wd:Q181600 wd:Q424771 wd:Q269829
p:P698
wds:Q51550717-9AE952EE-260C-45E0-9F74-EA2574351DCE
wdtn:P698
n8:11220295
wdt:P698
11220295
p:P1433
wds:Q51550717-E22DEE8B-9B5E-4EC0-A8DC-13262DEEE597
wdt:P1433
wd:Q5270109
p:P433
wds:Q51550717-4037264E-31BB-4924-95CB-50DBEA23069E
p:P478
wds:Q51550717-7969E018-E5AD-43C0-BEEB-FDEB59F2CB74
wdt:P433
3
wdt:P478
1
p:P356
wds:Q51550717-47F97672-E975-40F0-B568-FA3CE78372ED
wdtn:P356
n11:J.1463-1326.1999.00020.X
wdt:P356
10.1046/J.1463-1326.1999.00020.X